G6PD and G6PD deficiency: These findings correlate with those concluded by two recent studies assessing the performance of the CareStartTM G6PD RDT in screening G6PD deficiency in Thailand [46] and Cambodia [47], where 100 % sensitivity and NPV were found for the detection of <30 % G6PD activity against the quantitative G6PD assay.